TOKYO -- VLP Therapeutics Japan has begun a clinical trial of a new coronavirus vaccine that would require a far smaller dosage than those of Pfizer and Moderna, and could dramatically shorten production time, the company said Monday.
COVID vaccines
Japan startup VLP begins trial of new COVID vaccine
Shot requires smaller dose, allows faster production, CEO says
VLP Therapeutics Japan hopes to start Phase 2 and Phase 3 trials of its COVID-19 vaccine next spring. (Source photo by Reuters and VLP Therapeutics Japan website)
Read Next
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on COVID vaccines
